IGF2 knockdown reduced the MMP level and increased the production of reactive oxygen species (ROS) by suppressing downstream SIRT1/PGC1α expression in NAFLD [55]. The gene discussed is IGF2; the disease is metabolic dysfunction-associated steatotic liver disease.